Argent BioPharma Cash Flow Statement

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Net Income	-8.62	-17.84	-17.53	-20.82	-20.35	-15.87
Depreciation & Amortization	0.38	0.79	1.29	0.75	0.14	0.49
Loss (Gain) From Sale of Assets	0.12	0.12	-	-	-	-
Asset Writedown & Restructuring Costs	0.98	0.98	-	3.15	4.98	-
Loss (Gain) From Sale of Investments	1.41	1.41	-1.34	1.39	0.57	0.55
Stock-Based Compensation	3.96	3.96	3.64	2.66	0.52	1.65
Other Operating Activities	-7.96	-0.81	0.66	-1.17	0	4.7
Change in Accounts Receivable	0.29	0.29	-0.23	1.41	1.29	-2.22
Change in Inventory	0.74	0.74	0.49	0.48	-0.97	-0.47
Change in Accounts Payable	1.08	1.08	-1.64	0.19	1.63	-0.82
Operating Cash Flow	-7.61	-9.28	-14.66	-11.99	-12.16	-11.99
Capital Expenditures	-0	-0	-0.14	-0.19	-2.69	-3.33
Sale of Property, Plant & Equipment	0.21	0.21	-	-	-	-
Cash Acquisitions	-	-	-	-	0.15	-0.29
Divestitures	-	-	-	-	-	-0.08
Investment in Securities	-	-	-	-	-0.16	0.3
Other Investing Activities	-	-	-	0.8	1.59	2.45
Investing Cash Flow	0.21	0.21	-0.14	0.61	-1.11	-1.49
Long-Term Debt Issued	-	-	-	7.16	0.06	5.75
Short-Term Debt Repaid	-	-0.2	-	-	-	-
Long-Term Debt Repaid	-	-0.24	-0.24	-0.2	-0.26	-0.26
Total Debt Repaid	-0.43	-0.44	-0.24	-0.2	-0.26	-0.26
Net Debt Issued (Repaid)	2.57	-0.44	-0.24	6.96	-0.2	5.49
Issuance of Common Stock	6.05	10.4	15.94	3.09	10.7	12.76
Other Financing Activities	-0.41	-0.57	-0.44	-0.32	-0.76	-1.2
Financing Cash Flow	8.21	9.39	15.27	9.73	9.74	17.05
Foreign Exchange Rate Adjustments	0	-0	-0	-	-0.02	-0.01
Miscellaneous Cash Flow Adjustments	-	-	-	-	-0	-
Net Cash Flow	0.81	0.32	0.46	-1.65	-3.55	3.56
Free Cash Flow	-7.61	-9.28	-14.8	-12.18	-14.85	-15.32
Free Cash Flow Margin	-2189.04%	-5140.45%	-1661.19%	-359.40%	-313.85%	-511.23%
Free Cash Flow Per Share	-0.11	-0.16	-0.40	-4.13	-5.79	-8.04
Cash Interest Paid	-	-	-	0.26	0.03	-
Cash Income Tax Paid	-	-	-	0	-	-
Levered Free Cash Flow	-5.83	-4.51	-7.2	-5.54	-8.81	-12.6
Unlevered Free Cash Flow	-5.8	-4.47	-6.9	-5.37	-8.67	-12.37
Change in Working Capital	2.11	2.11	-1.39	2.07	1.96	-3.51

Source: S&P Global Market Intelligence. Standard template. Financial Sources.